Real-World Performance of the MiniMed 780G Advanced Hybrid Closed-Loop System in the Middle East, North Africa, and Türkiye Region

MiniMed 780G system RWE data in the MENAT region showed a sustained glycemic control that achieved international target criteria across different age groups, countries, and climate extremes. These findings align with RWE data from other geographies, validate the broad applicability of the MiniMed 780G benefits, and may help expand access to AID systems in the region.